Diagnostics: Fulfilling Its Potential
Join colleagues, health providers and researchers online for the inaugural 2023 Biomedical Diagnostics Global Discussion Series in collaboration with Thermo Fisher Scientific, a three-part series taking place June 14, September 13 and November 1, 2023.
The series of dynamic discussions will take place online. Each discussion will involve leading national experts in the chosen topic. Participants will be able to interact and ask questions as part of the discussion.
Registration: No cost.
Topics for the 2023 discussion series
Diagnostics: What do Healthcare Providers Know or Should Know about Diagnostics?
Nov. 15, 2023, 8 a.m. PST/11 a.m. EST/5 p.m. CEST
How, what and when do physicians/nurses learn about diagnostics? What incentives exist for providers and payers to use or not use testing? What role should diagnostics labs and manufacturers play in physician/healthcare provider education?
Speakers
Shami Feinglass
Fellow
The Aspen Institute
Nathan Ledeboer
Assistant professor of pathology and medical director of clinical microbiology
Medical College of Wisconsin
Tom Miller
Managing partner
GreyBird Ventures
Stan Rose
Managing partner
Rose Ventures
Mara Aspinall, moderator
Professor of practice
ASU College of Health Solutions<
Diagnostics Technologies: Lab of the Future
Sept. 20, 2023, 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST
What technologies will transform the lab of the future? How should labs best utilize their capacity? Where are the growth opportunities in the current lab infrastructure? What role does data and informatics play?
Speakers
Barb Jones
Chief executive officer
Clinical and Laboratory Standards Institute
Stephanie McCalla
Associate professor
Montana State University
Susan Realegeno
Scientific director
Quest Diagnostics
Mara Aspinall, moderator
Professor of practice
ASU College of Health Solutions
Diagnostics for the Healthy: The Screening Paradox
June 14, 2023, 8 a.m. PDT/11 a.m. EDT/5 p.m. CEST
What are the pros and cons of diagnostic screening from cancer to COVID-19 and beyond? Which tests are being over and underutilized? How can screening be economically feasible? Will we ever have effective screening tests from a single drop of blood?
Speakers
Dr. Karen Anderson
Professor
Biodesign Center for Personalized Diagnostics
Arizona State University
Associate professor of medicine
Mayo Clinic
Bruce J. Tromberg
Director
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health
Christina Clarke Dur
Epidemiology vice president
Distinguished scientist
GRAIL, Inc.
Mara Aspinall, moderator
Professor of practice
ASU College of Health Solutions
